97 related articles for article (PubMed ID: 12706459)
1. Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion.
Neudeck BL; Loeb J; Buck J
Eur J Pharmacol; 2003 Apr; 467(1-3):81-4. PubMed ID: 12706459
[TBL] [Abstract][Full Text] [Related]
2. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
Raffa RB; Baron DA; Tallarida RJ
Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
[TBL] [Abstract][Full Text] [Related]
3. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
[TBL] [Abstract][Full Text] [Related]
4. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
5. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.
Negus SS
Psychopharmacology (Berl); 2004 Nov; 176(2):204-13. PubMed ID: 15112031
[TBL] [Abstract][Full Text] [Related]
6. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures.
Chao CC; Gekker G; Hu S; Kravitz F; Peterson PK
Biochem Pharmacol; 1998 Aug; 56(3):397-404. PubMed ID: 9744578
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
Nazarian A; Krall CM; Osburn JR; McDougall SA
Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
[TBL] [Abstract][Full Text] [Related]
10. Local kappa opioid receptor activation decreases temporomandibular joint inflammation.
Chicre-Alcântara TC; Torres-Chávez KE; Fischer L; Clemente-Napimoga JT; Melo V; Parada CA; Tambeli CH
Inflammation; 2012 Feb; 35(1):371-6. PubMed ID: 21484425
[TBL] [Abstract][Full Text] [Related]
11. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
Kuzmin A; Sandin J; Terenius L; Ogren SO
J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific effects of the selective kappa-opioid receptor agonist U-50,488H on dopamine uptake and release in PC12 cells.
Chudapongse N; Kim SY; Kramer RE; Ho IK
J Pharmacol Sci; 2003 Nov; 93(3):372-5. PubMed ID: 14646257
[TBL] [Abstract][Full Text] [Related]
13. Renal responses to the kappa-opioid-receptor agonist U-50488H in conscious lambs.
Qi W; Ebenezar KK; Samhan MA; Smith FG
Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R162-8. PubMed ID: 17409260
[TBL] [Abstract][Full Text] [Related]
14. Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line.
Parkhill AL; Bidlack JM
Int Immunopharmacol; 2006 Jun; 6(6):1013-9. PubMed ID: 16644488
[TBL] [Abstract][Full Text] [Related]
15. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
16. Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice.
Shang Y; Guo F; Li J; Fan R; Ma X; Wang Y; Feng N; Yin Y; Jia M; Zhang S; Zhou J; Wang H; Pei J
J Cell Biochem; 2015 Feb; 116(2):252-9. PubMed ID: 25186835
[TBL] [Abstract][Full Text] [Related]
17. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
18. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
Ko MC; Butelman ER; Woods JH
J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
[TBL] [Abstract][Full Text] [Related]
19. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
20. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
